French guidelines for the diagnosis and management of Tourette syndrome

Autor: Hartmann, A., Ansquer, S., Brefel-Courbon, C., Burbaud, P., Castrioto, A., Czernecki, V., Damier, P., Deniau, E., Drapier, S., Jalenques, I., Marechal, O., Priou, T., Spodenkiewicz, M., Thobois, S., Roubertie, A., Witjas, T., Anheim, M.

Publikováno v: In Revue Neurologique October 2024 180(8):818-827

Pallidal neuronal activity in Gilles de la Tourette syndrome and dystonic patients: A comparative study.

Autor: Lamothe H; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France., Karachi C; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France.; Neurosurgery Department, APHP, Pitié-Salpêtrière Hospital, Paris, France., Lehongre K; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France., Buot A; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France., Grabli D; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France.; Neurology Department, APHP, Pitié-Salpêtrière Hospital, Paris, France., Thobois S; Neurology Department C, Expert Parkinson Centre, Hospices Civils de Lyon, Pierre Wertheimer Neurological Hospital, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C - Hospices Civils de Lyon, Bron, France., Burguière E; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France., Giordana C; Neurology Department, Nice, Centre, France., Houeto JL; Neurology Department, CHU Limoges, Limoges, France., Mallet L; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France.; Département Médical-Universitaire de Psychiatrie et d'Addictologie, APHP, Univ Paris-Est Créteil, DMU IMPACT, Hôpitaux Universitaires Henri Mondor - Albert Chenevier, Créteil, France.; Global Health Institute and Department of Mental Health and Psychiatry, University of Geneva, Geneva, Switzerland., Vidailhet M; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France.; Neurology Department, APHP, Pitié-Salpêtrière Hospital, Paris, France., Welter ML; Inserm 1127, Sorbonne Université, UPMC Univ Paris 06, UMRS 1127, CNRS, UMR 7225, Paris Brain Institute, Paris, France.; Neurophysiology department, CHU Rouen, University of Normandy, Rouen, France.

Publikováno v: The European journal of neuroscience [Eur J Neurosci] 2024 Nov; Vol. 60 (9), pp. 6185-6194. Date of Electronic Publication: 2024 Oct 12.

Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study.

Autor: Marques A; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France. ar_marques@chu-clermontferrand.fr.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France. ar_marques@chu-clermontferrand.fr.; Neurology Department, Parkinson Expert Center, CHRU Gabriel Montpied, 63000, Clermont-Ferrand, France. ar_marques@chu-clermontferrand.fr., Macias E; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Pereira B; Clermont-Ferrand University Hospital, Biostatistics Unit (DRCI), Clermont-Ferrand, France., Durand E; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Chassain C; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Vidal T; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Defebvre L; Department of Movement Disorder and NS-PARK/FCRIN Network, Inserm 1172, University of Lille, Lille, France., Carriere N; Department of Movement Disorder and NS-PARK/FCRIN Network, Inserm 1172, University of Lille, Lille, France., Fraix V; Université Grenoble Alpes, CHU de Grenoble, Service de Neurologie, Grenoble Institute of Neuroscience, and NS-PARK/FCRIN Network, Grenoble, France., Moro E; Université Grenoble Alpes, CHU de Grenoble, Service de Neurologie, Grenoble Institute of Neuroscience, and NS-PARK/FCRIN Network, Grenoble, France., Thobois S; CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229 CNRS, Lyon, France.; Université Claude Bernard, Lyon I, Lyon, France.; Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C and NS-PARK/FCRIN Network, Lyon, France., Metereau E; CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229 CNRS, Lyon, France.; Université Claude Bernard, Lyon I, Lyon, France.; Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Service de Neurologie C and NS-PARK/FCRIN Network, Lyon, France., Mangone G; Département de Neurologie and NS-PARK/FCRIN Network, Sorbonne Université; Institut du Cerveau-ICM, Assistance Publique Hôpitaux de Paris; Inserm 1127, CNRS 7225, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France., Vidailhet M; Département de Neurologie and NS-PARK/FCRIN Network, Sorbonne Université; Institut du Cerveau-ICM, Assistance Publique Hôpitaux de Paris; Inserm 1127, CNRS 7225, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France., Corvol JC; Département de Neurologie and NS-PARK/FCRIN Network, Sorbonne Université; Institut du Cerveau-ICM, Assistance Publique Hôpitaux de Paris; Inserm 1127, CNRS 7225, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France., Lehéricy S; Département de Neuroradiologie and NS-PARK/FCRIN Network, Sorbonne Université; Institut du Cerveau-ICM, Assistance Publique Hôpitaux de Paris; Inserm 1127, CNRS 7225; Hôpital Pitié-Salpêtrière, Paris, France., Menjot de Champfleur N; Department of Neuroradiology, Montpellier University Hospital Center, Gui de Chauliac Hospital, Montpellier, France.; I2FH, Institut d'Imagerie Fonctionnelle Humaine, Hôpital Gui de Chauliac, CHRU de Montpellier, Montpellier, France., Geny C; Department of Geriatrics and NS-PARK/FCRIN Network, Montpellier University Hospital, Montpellier University, Montpellier, France., Spampinato U; Service de Neurologie-Maladies Neurodégénératives and NS-PARK/FCRIN Network, CHU Bordeaux, 33000, Bordeaux, France.; INCIA-UMR 5287, Team P3TN, CNRS/Université de Bordeaux, Bordeaux, France., Meissner WG; Service de Neurologie-Maladies Neurodégénératives and NS-PARK/FCRIN Network, CHU Bordeaux, 33000, Bordeaux, France.; Univ. Bordeaux, CNRS, IMN, UMR 5293, Bordeaux, 33000, Bordeaux, France.; Dept. Medicine, University of Otago, Christchurch, New Zealand.; New Zealand Brain Research Institute, Christchurch, New Zealand., Frismand S; Department of Neurology and NS-PARK/FCRIN Network, Nancy University Hospital Center, Nancy, France., Schmitt E; Department of Neuroradiology, Nancy University Hospital Center, Nancy, France., Doé de Maindreville A; Department of Neurology and NS-PARK/FCRIN Network, Hôpital Maison Blanche, Reims, France., Portefaix C; Department of Radiology, Hôpital Maison Blanche, Reims, France.; CReSTIC Laboratory, University of Reims Champagne-Ardenne, Reims, France., Remy P; Centre Expert Parkinson and NS-PARK/FCRIN Network, CHU Henri Mondor; AP-HP et Equipe Neuropsychologie Interventionnelle, INSERM-IMRB, Faculté de Santé, Université Paris-Est Créteil et Ecole Normale Supérieure Paris Sorbonne Université, Créteil, France., Fénelon G; Centre Expert Parkinson and NS-PARK/FCRIN Network, CHU Henri Mondor; AP-HP et Equipe Neuropsychologie Interventionnelle, INSERM-IMRB, Faculté de Santé, Université Paris-Est Créteil et Ecole Normale Supérieure Paris Sorbonne Université, Créteil, France., Houeto JL; INSERM, CHU de Poitiers, Université de Poitiers, Centre d'Investigation Clinique CIC1402; Service de Neurologie and NS-PARK/FCRIN Network, Poitiers, France.; CHU-Centre Expert Parkinson de Limoges, Limoges, France., Colin O; INSERM, CHU de Poitiers, Université de Poitiers, Centre d'Investigation Clinique CIC1402; Service de Neurologie and NS-PARK/FCRIN Network, CH Brive la Gaillarde, Poitiers, France., Rascol O; Centre Expert Parkinson, Départements de Pharmacologie Clinique et Neurosciences, Centre d'Investigation Clinique CIC 1436, UMR 1214 TONIC, NeuroToul and NS-PARK/FCRIN Network, INSERM, CHU de Toulouse et Université de Toulouse3, Toulouse, France., Peran P; ToNIC, Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France., Bonny JM; INRAE, UR QuaPA, 63122, Saint-Genès-Champanelle, France.; Nuclear Magnetic Resonance Facility for Agronomy, Food and Health, AgroResonance, INRAE, 2018, Saint-Genès-Champanelle, France., Fantini ML; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France., Durif F; University Clermont Auvergne, CNRS, Clermont Auvergne INP, IGCNC, Institute Pascal, Clermont-Ferrand, France.; Neurology Department and NS-PARK/FCRIN Network, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Publikováno v: Journal of neurology [J Neurol] 2023 Dec; Vol. 270 (12), pp. 6033-6043. Date of Electronic Publication: 2023 Aug 31.

Feasibility of changing for a rechargeable constant current neurostimulator in Parkinson's disease

Autor: Wirth, T., Laurencin, C., Berthillier, J., Brinzeu, A., Polo, G., Simon, E., Mertens, P., Broussolle, E., Danaila, T., Thobois, S.

Publikováno v: In Revue Neurologique March 2021 177(3):283-289

Deep brain stimulation for severe dystonia associated with Wilson disease: A prospective multicenter meta-analysis of an N-of-1 trial.

Autor: Laurencin C; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France.; Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR5292, PATH-PARK Team, University Lyon 1, Lyon, France.; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Femme Mère Enfant Hospital, Hospices Civils de Lyon, Bron, France., Poujois A; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Neurology Department, Rothschild Foundation Hospital, Paris, France., Bonjour M; Department of Biostatistics, Hospices Civils de Lyon, Lyon, France.; Laboratoire de Biométrie et Biologie Évolutive, University Lyon 1, Villeurbanne, France.; Faculté de Médecine Lyon Est, University Lyon 1, Lyon, France., Demily C; Reference Center for Rare Diseases With Psychiatric Phenotype Génopsy, Le Vinatier Hospital, Bron, France., Klinger H; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France., Roze E; Sorbonne University, INSERM, CNRS, Paris, France.; Brain Institute, Assistance Publique Hôpitaux de Paris, Salpêtrière Hospital, Paris, France., Leclert V; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France., Danaila T; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France., Langlois-Jacques C; Department of Biostatistics, Hospices Civils de Lyon, Lyon, France.; Laboratoire de Biométrie et Biologie Évolutive, University Lyon 1, Villeurbanne, France.; Faculté de Médecine Lyon Est, University Lyon 1, Lyon, France., Couchonnal E; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Femme Mère Enfant Hospital, Hospices Civils de Lyon, Bron, France., Woimant F; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Neurology Department, Rothschild Foundation Hospital, Paris, France., Obadia MA; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Neurology Department, Rothschild Foundation Hospital, Paris, France., Perez G; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Neurology Department, Rothschild Foundation Hospital, Paris, France., Pernon M; National Reference Center for Wilson Disease and Other Copper-Related Rare Diseases, Neurology Department, Rothschild Foundation Hospital, Paris, France., Blanchet L; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France., Broussolle E; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France., Vidailhet M; Sorbonne University, INSERM, CNRS, Paris, France.; Brain Institute, Assistance Publique Hôpitaux de Paris, Salpêtrière Hospital, Paris, France., Kassai B; Centre d'Investigation Clinique 1407, Hospices Civils de Lyon, Louis Pradel Hospital, Bron, France., Moro E; Division of Neurology CHU Grenoble Alpes, Grenoble Institute of Neurosciences, INSERM U1216, Grenoble Alpes University, Grenoble, France., Karachi C; Neurosurgery Department, Hôpital de la Salpêtrière, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France., Polo G; Neurosurgery Department A, Hospices Civils de Lyon, Pierre Wertheimer Neurological Hospital, Bron, France., Grabli D; Sorbonne University, INSERM, CNRS, Paris, France.; Brain Institute, Assistance Publique Hôpitaux de Paris, Salpêtrière Hospital, Paris, France., Portefaix A; Centre d'Investigation Clinique 1407, Hospices Civils de Lyon, Louis Pradel Hospital, Bron, France., Thobois S; Department of Neurology C, Parkinson Expert Center, Pierre Wertheimer Neurological Hospital, Hospices Civils de Lyon, Bron, France.; Lyon Neuroscience Research Center, INSERM U1028, CNRS UMR5292, PATH-PARK Team, University Lyon 1, Lyon, France.

Publikováno v: European journal of neurology [Eur J Neurol] 2024 Oct 29, pp. e16524. Date of Electronic Publication: 2024 Oct 29.